The deadly cross-talk between Hippo pathway and epithelial–mesenchymal transition (EMT) in cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11033-022-07590-z.pdf
Reference94 articles.
1. Zygulska AL, Krzemieniecki K, Pierzchalski P (2017) Hippo pathway—brief overview of its relevance in cancer. J Physiol Pharmacol 68(3):311–335
2. Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH, Peng X, Ge Z, Chen H, Li J, Chen Z, Zhang H, Han L, Du D, Creighton CJ, Mills GB (2018) Comprehensive molecular characterization of the Hippo signaling pathway in cancer. Cell Rep 25(5):1304-1317.e5. https://doi.org/10.1016/j.celrep.2018.10.001
3. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, Israel MA, Goldstein LS, Abujarour R, Ding S, Guan KL (2010) The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 24(11):1106–1118. https://doi.org/10.1101/gad.1903310
4. Morice S, Danieau G, Rédini F, Brounais-Le-Royer B, Verrecchia F (2020) Hippo/YAP signaling pathway: a promising therapeutic target in bone paediatric cancers? Cancers (Basel) 12(3):645. https://doi.org/10.3390/cancers12030645
5. Kalluri R, Weinberg RA (2009) The basics of epithelial–mesenchymal transition. J Clin Investig 119(6):1420–1428. https://doi.org/10.1172/JCI39104
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics;European Journal of Medicinal Chemistry;2024-10
2. Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors;Pathology - Research and Practice;2024-10
3. The role of liquid-liquid phase separation in defining cancer EMT;Life Sciences;2024-09
4. Amphiregulin Downregulates E-cadherin Expression by Activating YAP/Egr-1/Slug Signaling in SKOV3 Human Ovarian Cancer Cells;Reproductive Sciences;2024-08-13
5. Breast cancer drug resistance: Decoding the roles of Hippo pathway crosstalk;Gene;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3